Vezatin, a protein associated to adherens junctions in epithelial cells, is already expressed in mouse oocytes and during pre-implantation development. Using a floxed strategy to generate a vezatin-null allele, we show that the lack of zygotic vezatin is embryonic lethal, indicating that vezatin is an essential gene. Homozygous null embryos are able to elicit a decidual response but as early as day 6.0 postcoitum mutant implantation sites are devoid of embryonic structures. Mutant blastocysts are morphologically normal, but only half of them are able to hatch upon in vitro culture and the blastocyst outgrowths formed after 3.5 days in culture exhibit severe abnormalities, in particular disrupted intercellular adhesion and clear signs of cellular degeneration. Notably, the junctional proteins E-cadherin and b-catenin are delocalized and not observed at the plasma membrane anymore. These in vitro observations reinforce the idea that homozygous vezatin-null mutants die at the time of implantation because of a defect in intercellular adhesion. Together these results indicate that the absence of zygotic vezatin is deleterious for the implantation process, most likely because cadherin-dependent intercellular adhesion is impaired in late blastocysts when the maternal vezatin is lost.
Introduction
Intercellular adhesion and junction formation play a major role during the first morphogenetic events involved in the development of the mouse embryo (Johnson and McConnell, 2004; Yamanaka et al., 2006) . At the 8-cell stage, during compaction, individual blastomeres forming a morula become polarized both at the cell surface and in the cytoplasm (Louvet et al., 1996; Vinot et al., 2005) . They maximize their contacts and flatten upon each other through the formation of adherens junctions (Johnson and Ziomek, 1981; Ziomek and Johnson, 1980) . Once blastomeres are polarized, they can divide asymmetrically, leading to the formation of inside non-polarized cells, and outside polarized blastomeres at the 16-cell stage. This process of asymmetrical cell divisions is essential for the divergence of the first two cell lineages, the trophectoderm (TE) and the inner cell mass (ICM). Although cell-cell interactions are not seemingly required for the polarization of 8-cell blastomere, since it can take place in the absence of intercellular contacts (Houliston et al., 1989) , they are an absolute requirement for blastocyst morphogenesis. In the blastocyst, intercellular junctions maintain the integrity of the TE, the outer layer of epithelial cells, which surrounds a undifferentiated cell cluster, the inner cell mass (ICM) at the 32-cell stage (Fleming et al., 2000 (Fleming et al., , 2001 Johnson and McConnell, 2004; Watson and Barcroft, 2001; Yamanaka et al., 2006) . The TE plays an essential role in blastocyst morphogenesis as the transition to a continuum of functional junctions is tightly coupled to the physiological control of the internal environment generating a fluid-filled cavity, the blastocoele. Before implantation, the fully cavitated blastocyst hatches from the zona pellucida (ZP). The TE becomes adhesive, expressing integrins that enable the embryo to bind the extracellular matrix of the uterine wall (Cross et al., 1994; Wang and Dey, 2006) . E-cadherin, the prototype of the Ca 2+ -dependent adhesive cadherin family, was the first adhesion molecule identified in the mouse embryo (Hyafil et al., 1980; Kemler et al., 1977) . E-cadherin plays a pivotal role during compaction, at late eight-cell stage, when cell-cell adhesion is triggered (Vestweber and Kemler, 1985) . Early after fertilization and until compaction, the protein is evenly inserted into the blastomere cortical membrane. At compaction, functional E-cadherin redistributes at basolateral contacts, through homophilic interactions between molecules from neighbouring cells, and induces cell-cell adhesion and flattening of the blastomeres. This is followed by the differentiation of the first epithelium, the trophoblast, and, later, by the formation of the different embryonic epithelial layers. Experiments aimed at disturbing early cell-cell interactions in compacting embryos are all associated with an alteration of E-cadherin localization at the plasma membrane (Clayton et al., 1999; Hyenne et al., 2005; Ohsugi et al., 1997; Pey et al., 1998) . Embryos homozygously deficient in E-cadherin are unable to maintain compaction and to form an intact trophectoderm layer, although the maternal protein is sufficient to mediate a weak intercellular adhesion of early blastomeres until the blastocyst stage Larue et al., 1994; Riethmacher et al., 1995) . This proves that E-cadherin is required for morphogenesis of the blastocyst, but that adhesion mediated by E-cadherin is not essential for the very early stages of mouse pre-implantation development .
Vezatin, a transmembrane protein, is a more recently identified component of the E-cadherin-catenins complex at adherens junctions (Kussel-Andermann et al., 2000; Sousa et al., 2004) . Vezatin has properties reminiscent of those of E-cadherin (Hyenne et al., 2005) : (i) it is expressed already in the oocyte at fertilization and then throughout development, (ii) it localizes all around the cell cortex before compaction and, after compaction, redistributes to the basolateral domains in cell-cell adherens junctions and (iii) downregulation of vezatin through the use of specific morpholino oligonucleotides leads to a severe loss of blastomeres adhesion together with a delocalization of E-cadherin and b-catenin from cell-cell contacts and a strong decrease in E-cadherin mRNA and protein contents (Hyenne et al., 2005) . However, specific inhibition of vezatin translation by morpholino oligonucleotides induces a cell division arrest making impossible to evaluate the role of vezatin during the later stages of blastocyst development and at implantation.
We generated a loss-of-function allele through the use of a loxP-tagged (fl) vezatin locus in combination with the early and uniform activation of a Pgk-1-cre transgene in vivo (Lallemand et al., 1998) . Our results indicate that the zygotic vezatin gene is essential for the late stages of pre-implantation development in vivo: lack of vezatin induces disruption of adherens junctions in both embryonic and extra-embryonic tissues at the time of implantation once the maternal protein has disappeared.
Results

Disruption of the murine vezatin gene
The mouse vezatin gene encodes several alternatively spliced mRNA isoforms expressed in early development ( Fig. 1A) : two of them, vezatin 2.4 kb (AY753561) (predicted protein with an estimated molecular mass of 86 kDa) and vezatin 1.9 kb (AY753562) (predicted protein with an estimated molecular mass of 68 kDa) were already described (Hyenne et al., 2005) . Vezatin 0.8 kb (DQ025533, estimated molecular mass of 31 kDa), is a transcript that we identified through a databases search using embryonic stem cells mRNA as template. RT-PCR analysis on embryos at the 2, 8-cell and blastocyst stages (Hyenne et al., 2005) shows that vezatin 0.8 kb is expressed at low level at the blastocyst stage ( Fig. 1 Supplementary data). The predicted mouse vezatin isoforms encoded by these three mRNA species share the same extracellular and transmembrane domains but differ by their cytoplasmic region (see Fig. 1A ). Contrary to the vezatin gene in primates which present two possible ATG codons (Homo sapiens and Pan troglodytes), a unique initiation codon is present in the mouse. To inactivate the gene, we used a cre/loxP strategy in order to generate a vezatin allele lacking exon 5 (Vezt dfl , Fig. 1B ). Because this exon codes for the transmembrane domain (see Fig. 1A ), vezatin proteins potentially produced from this allele are unlikely to sustain normal vezatin functions.
Homologous recombinant ES cell clones were selected, cell amplified, checked again by Southern blot analysis, after cell amplification (Fig. 1C) . One selected clone gave germ line transmission (see Section 4). The floxed allele (fl) is identified as Vezt tm1Smc (MGI: 3618233) or alternatively Vezt fl for better clarity within the manuscript (see Fig. 1B ). Vezt fl/fl males and females were crossed with Pgk-1-cre mice to generate double heterozygous Vezt fl/+ , Pgk-1-cre/+ animals. In the Pgk-1-cre line, the transgene driving the cre recombinase activity is under the control of the ubiquitously expressed Pgk-1 gene. It is expressed from E3.5 onwards, when paternally inherited, and from oogenesis onwards, when maternally inherited (Lallemand et al., 1998) .
All mice born, with no exception, carry the simultaneous deletion of the neomycin gene and of the exon 5 of the vezatin gene (fully defloxed allele, dfl) as expected since the cre activity drived by the Pgk-1 promoter is uniform and efficient (Lallemand et al., 1998) (Fig. 2 Supplementary data). The fully defloxed allele (dfl) is identified as Vezt tm1.1Smc (MGI: 3618234) or alternatively Vezt dfl (Fig. 1B) . Thus, all animals that carry the cre transgene are heterozygous, carrying one copy of the fully defloxed allele (410 bp, see the dfl-PCR) and one copy of the wild type allele (1108 bp, see the wt-1-PCR). The floxed allele (1063 bp, see the fl-PCR) was never observed in these animals. DNA from a Vezt fl/+ mouse without the cre transgene was used as a control ( Fig. 2 Supplementary data). Vezt dfl/+ mice are born at expected frequency with no overt phenotype.
Because exons 4 and 6 are in frame, truncated proteins could theoretically be produced from the Vezt dfl allele. To address this point, we performed western blot analysis of adult wild type testis and brain protein using an affinity-purified anti-vezatin antibody directed against the C-terminal region ( Fig. 2A) . This antibody recognizes either the protein encoded by the vezatin-2.4 kb transcript (predicted molecular mass of 86 kDa) and/or by the vezatin-1.9 kb transcript (predicted molecular mass of 68 kDa) (see Fig. 1A ). We observed two major bands exhibiting electrophoretic mobilities which are substantially greater than predicted (125 and 90 kDa vs 86 and 68 kDa) (Kussel-Andermann et al., 2000; Hyenne et al., 2007) . Whether such retarded migration is due to vezatin proteins intrinsic properties or to post-translational modifications is unknown yet. Noticeably, western blot analysis of adult testis and brain proteins from Vezt dfl/+ mice showed that the amount of the two major bands were about half that measured in wild type ( Fig. 2A) . Importantly, using this antibody or the N-terminally targeted antibodies hA34P1 (Kussel-Andermann et al., 2000) , no additional bands were observed in extracts from Vezt dfl/+ mice when compared to extracts from wild type mice ( Fig. 2A and Fig. 3 Supplementary data). Therefore, these observations suggest that the truncated proteins coded by the Vezt dfl allele, if produced, are rapidly degraded after their synthesis (McCracken and Brodsky, 2003) . Molecules of the proteasome complex able to degrade misfolded truncated proteins are indeed abundantly expressed in full-grown oocytes and 2-cell stage embryos and later in mouse development (Hamatani et al., 2004) . Thus, we conclude from our results that the Vezt dfl allele corresponds to a loss-of-function mutation.
Embryonic lethality of vezatin-null embryos
To generate homozygous Vezt dfl/dfl mice, Vezt fl/+ Pgk-1-cre/+ were intercrossed. Genotyping of 81 offspring revealed the absence of mice homozygous for the vezatin mutation (Vezt dfl/dfl ) ( Table 1A and Fig. 2B ). Similarly, no mice homozygous for the vezatin null allele were born from Vezt fl/+ Pgk-1-cre/+ male mice backcross to Vezt fl/fl female mice (Vezt fl/+ Pgk-1-cre/+ · Vezt fl/fl ) (n = 30) ( Table 1A) .
To determine the developmental stage at which homozygous embryos die, uteri from timed mating females were examined. Genotype analysis of embryos dissected at E9.5 (n = 31) and at E8.5 (n = 9), revealed that no homozygous Vezt dfl/dfl embryos were present, while approximately 30% of deciduae were empty, indicating embryo resorption at earlier stages (Table 1B ). These data demonstrate that vezatin is essential during preor peri-implantation. This also suggests that vezatin is not required for inducing decidual swelling in vivo.
Based on these observations, uteri from intercrossed heterozygous Vezt dfl/+ mice were dissected out and deciduae examined histologically to obtain morphological information with regards to vezatin developmental defects just after implantation. We examined uteri at E6.0 and at E6.5 days post-coitus. We performed serial sectioning of 25 deciduae (9 for E6.0 and 16 at E6.5), which were stained with hematoxylin and eosin and dfl/+ mouse (lanes 2 and 4) compared to a wild type control (lanes 1 and 3) using the affinity-purified anti-vezatin antibodies Two major bands are identified at 125 and 90 kDa (arrows). A third minor band at $80 kDa is inconstantly detected. Quantification was carried out by comparing vezatin and a-tubulin levels of the highest (125 kDa) of the two major bands. The expression of the protein was 44,2% (testis) and 69% (brain) of that of the tubulin protein (see diagram). (B) No Vezt dfl/dfl is born alive. Genotyping of a littermate derived from an intercross between Vezt dfl/+ mice, using the dfl-PCR conditions which amplify both the dfl and the wt-1 alleles: out of 12 mice, 8 and 4 are Vezt dfl/+ and Vezt
Vezt dfl/dfl embryos are present in blastocyst outgrowths. Examples of genotyping of blastocysts after 3.5 days in culture from intercrosses between Vezt dfl/+ mice, using the dfl-PCR conditions which amplify both the dfl and the wt-2 alleles, under conditions which facilitate PCR using limited amount of material. Out of 13 outgrowths shown here, 9, 1 and 3 are Vezt dfl/+ , Vezt +/+ and Vezt dfl/dfl , respectively. entirely analyzed. In 19 deciduae, a normal embryo was clearly observed, with an elongated egg-cylinder, extraembryonic and embryonic tissues surrounding a proamniotic cavity and a normal decidua at E6.0 ( Fig. 3A) and at E6.5 (Fig. 3C ). The other 6 deciduae did not contain embryonic material (4 out of 9, at E6.0 (Fig. 3B ) and 2 out of 16, at E6.5 (Fig. 3D) ). No ectoplacental cone, epiblast or trophoblastic giant cells could be identified in these abnormal implantation sites. The ratio of deciduae containing a resorbed embryo (6/ 25, 24%) was close to Mendelian ratios expected for the appearance of Vezt dfl/dfl embryos. In addition, we genotyped 8 normally developed embryos at E6.5 days of gestation. All of them were carrying at least one wild type allele (data not shown). Although a contamination by heterozygous maternal tissues cannot be excluded, this suggests that embryos able to implant are wild type or heterozygous embryos.
Altogether, these results suggest that Vezt dfl/dfl embryos may reach the blastocyst stage since they are able to induce a decidual reaction but that the embryo proper did not progress further and died before the egg cylinder stage. This led us to investigate in vitro the developmental competence of blastocysts obtained from Vezt dfl/+ intercrosses.
Vezatin-null blastocysts are unable to form normal embryonic outgrowth in vitro
First, E3.5 blastocysts isolated from Vezt dfl/+ intercrosses were grown in culture for one day, then genotyped. Nineteen blastocysts developing normally (see below) were either Vezt dfl/+ (15/22) or Vezt +/+ (4/22). Three retracted blastocysts were Vezt dfl/dfl (3/22). Then, a large population of E3.5 blastocysts isolated from Vezt dfl/+ intercrosses were grown in culture for 3.5 days, photographed daily (D0, D1, D2 and D3.5, see details for the precise timing in the legend of Fig. 4 ) and genotyped at D3.5. Of 131 embryos, 33 were Vezt +/+ , 60 were Vezt dfl/+ and 38 were Vezt dfl/dfl (Fig. 2C ), these numbers (25.2%, 45.9% and 27.5%) being close to the values expected for Mendelian inheritance (Table 2A) .
At D0, Vezt +/+ , Vezt dfl/+ and Vezt dfl/dfl blastocysts were indistinguishable in size and aspect (Fig. 4) , Vezt +/+ and Vezt dfl/dfl embryos. E3.5 blastocysts from Vezt dfl/+ intercrosses were cultured in vitro for 3.5 days. D0, D1, D2 and D3.5 correspond to time 0 +4 h, +28 h, +52 h and +84 h after plating at time 0. Arrows point to the ICM, and trophoblastic normal giant cells (TGC) and abnormal fiberlike structures (fibers) are indicated. Genotypes were determined by PCR afterwards. ZP, zona pellucida. The scale bars represent 50 lm. different (p < 0.0001, using the v 2 test). At 3.5 days in culture, the vast majority of the Vezt +/+ (88%, 29/33) and Vezt dfl/+ (95%, 57/60) embryos showed a normal outgrowth of trophoblastic cells surrounding a central mass of cells composed of the ICM derivatives (Table 2A and Fig. 4) . In contrast, none of the 38 Vezt dfl/dfl embryos behave normally (38/38 were classified as abnormal outgrowths) (Fig. 4 and Table 2A) .
Mutant outgrowths were sub-classified into three types after 3.5 days in culture: type I: no in vitro hatching; type II: delayed abnormal outgrowth and type III: abnormal outgrowth. Type I were still in the ZP with a decompacted aspect. Cells were loosely adherent and rounded, enclosed into the ZP (Fig. 4) . Type II were still surrounded by the ZP by day 2 (D2), but one day later (D3.5), they hatched and started to adhere to the extracellular matrix. ICM were small and disorganized, with loosely adherent cells and many trophoblastic cells had elongated fiber-like structures (Fig. 4) . Type III hatched normally and adhered from day 2 (D2). However, at day 3.5 in culture (D3. Table 2A ). Thus, only 7.5% (7/93) of wild type or heterozygous embryos displayed an abnormal phenotype (a percentage within the range of the limits of the in vitro culture system) while 100% (38/38) of homozygous mutant embryos were abnormal. This is clearly due to vezatin deletion.
Loss of vezatin induces a loss of adherens junctions
E3.5 embryos from Vezt dfl/+ intercrosses were cultured and outgrowths were analyzed by immunostaining at day 2 (D2) and at day 3.5 (D3.5) in culture, in two separate experiments. Immunostaining was performed with the affinity-purified polyclonal anti-vezatin antibody (Hyenne et al., 2005) , the rat monoclonal anti-E-cadherin antibody, DECMA-1 (Vestweber and Kemler, 1985) , or a mouse monoclonal anti-b-catenin antibody. After 2 days in culture (D2), 25 out of 30 blastocysts examined were scored as normal outgrowths with spread trophoblastic cells and well developed ICM cell clusters. All normal outgrowths showed a colocalization of the three proteins (vezatin, E-cadherin and b-catenin) at cell-cell junctions ( Fig. 5A and B) . Five of them that were well individualized on the slide and thus suitable for genotyping, were heterozygous or wild type outgrowths. The 5 abnormaly growing embryos were still in the ZP, with a type I phenotype. They were briefly treated with acid Tyrode to remove the ZP and fixed. Embryonic cells from 2 abnormal embryos were lost as soon as the ZP was removed, reinforcing the idea that the ZP was maintaining these loosely associated cells together. In the three remaining abnormal embryos, although the blastocysts showed a retraction of the cavity, the three junctional proteins were still partly localized to intercellular contacts (Fig. 4 Supplementary data). Two of these retracted embryos were successfully genotyped afterwards; both were homozygous mutant. This indicated that the maternally derived vezatin protein can be detected in blastocysts cultured for two days and is sufficient to maintain some junctional complexes at the membrane.
Outgrowths after 3.5 days in culture (D3.5) were examined by morphological analysis, whole mount immunostaining and genotyping. From 60 outgrowths, 47 and 13 were scored as normal and abnormal, respectively (Table 2B) . Cells from 2 type I abnormal outgrowths disaggregated and were lost during experimental harvesting. Similarly, the majority of the poorly adherent ICM-derived cells from abnormal outgrowths classified as type II or type III were lost. This behavior was not encountered in normal adherent outgrowths. Seventeen outgrowths (12 normal and 5 abnormal) were successfully genotyped after immunostaining. The 12 Fig. 6E . b Illustrated in Fig. 6I . c This type II abnormal outgrowth is not the one illustrated in Fig. 6 since it disassembled to a large extend during the immunostaining procedure, although it was successfully genotyped afterwards.
d Illustrated in Fig. 6Q . The distribution of embryos phenotypes in the group that was successfully genotyped (n = 17) does not differ significantly from the one observed in the starting group (n = 60), using the v 2 test (p = 0.895).
normal outgrowths were either Vezt +/+ or Vezt dfl/+ (Table 2B ). The junctional proteins colocalized in normal outgrowths after 3.5 days in culture (Fig. 5C , at high magnification and Fig. 6B-D) . Amongst the 5 abnormal outgrowths, 4 were Vezt dfl/dfl and 1 was Vezt dfl/+ (see below). Cell-cell adhesion was severely impaired in all 4 Vezt dfl/dfl outgrowths. In the type I mutant, all cells were rounded, some being even externalized and the zona pellucida seemed to keep together the cohesion of the embryo, a phenotype already visible, before immunostaining (see Fig. 6I ) and confirmed at the level of the immunochemical analysis (see Fig. 6J -L and Fig. 7A and B). In the type II-and III-mutants, remnants of the ICM containing only few cells (white arrows) as well as trophoblastic cells with fiber-like structures, were evident ( Fig. 6M and Q) . In all cases, although vezatin and the two other junctional proteins were apparently still weakly present (E-cadherin not shown, see legend to Fig. 6 ), all markers were completely displaced from the plasma membrane to cytoplasmic areas (see Fig. 6T ) and/or fiber-like regions (see Fig. 6p ). The abnormal outgrowth, genotyped as Vezt dfl/+ (Fig. 6E ), corresponded to an embryo which only displayed a small cavity during the culture period. Vezatin (Figs. 6F, H and 7C ), E-cadherin (data not shown) and b-catenin were immunodetected at cell-cell contacts (Figs. 6G, H 
Discussion
In the present study, we demonstrate a critical role for vezatin at the time of implantation of the mouse embryo. Indications for embryonic lethality are that (i) no living homozygous mutants were born and (ii) no homozygous mutant embryos were recovered from dissections at embryonic day E6.0 onwards. We suspect that the lethality is around the time of implantation because the number of deciduae that are empty at E6.0 and E6.5 fits with the expected number of homozygous mutants. Moreover, all vezatin-null blastocyst outgrowths show a disorganization of embryonic structures associated with a loss in cell-cell adhesion.
Vezatin is known to be already expressed in the oocyte and is present at all stages of early development (Hyenne et al., 2005) . At E3.5, homozygous vezatin-null blastocysts are apparently morphologically indistinguishable from their wild type and heterozygous counterparts, suggesting that the formation of adhesion complexes required for the differentiation of the first epithelium, the TE, is not affected by the zygotic elimination of the vezatin gene (Fig. 8) Eshkind et al., 2002) . Similarly to our observations in vezatin-null embryos, defect in zygotic E-cadherin (Cdh1), coding for the prototypical calcium-dependent cell-cell adhesion protein, leads to a dramatic loss of cell-cell contacts at E4.5 in late blastocysts (Larue et al., 1994; Riethmacher et al., 1995) . Defect in aE-catenin (Ctnna1), a gene coding for a protein at the junction of intercellular adhesion and actin dynamics, also results in embryonic lethality around E4.5 (Torres et al., 1997 ) with a loss of adhesiveness very similar to the phenotype associated with the lack of vezatin and E-cadherin. When mutant blastocyst development was followed in culture, about half of the mutant embryos never hatched in in vitro culture conditions and lost their expanded blastocyst morphology, with retraction of the cavity. The other half of the mutant embryos finally hatched and partly attached in culture. Interestingly, a variability in the morphology of cultured E-cadherin-null embryos was also noted (Ohsugi et al., 1997) . In vezatin-null outgrowths, the ICM did not expand as a dense core structure: ICM were small and loosely organized due most likely to a decrease in intercellular adhesion. Abnormal trophectoderm cells displayed a retracted fiber-like aspect. These data support the idea that absence of vezatin induces a loss of cellular adhesiveness as the maternal supplied protein is lost in late blastocysts. This is more obvious in ICM-derived, highly dividing cells than in non-dividing trophoblastic cells. Moreover, while all homozygous mutant blastocysts were indistinguishable from the control heterozygous/wild type embryos at E3.5, one day later, 92% formed delayed/abnormal in vitro outgrowth, suggesting that the maternal protein is progressively lost from E4.5 onwards (Fig. 8) . Our in vitro results thus suggest that in vivo, vezatin-null embryos should die shortly after blastocyst formation at the time of implantation (E4.5-E5.5).
Vezatin-null embryos are capable of eliciting a decidual response in vivo, although no embryonic structures are present in implantation sites. This fits with the fact that more than half of the vezatin-null blastocysts may outgrow in vitro and form a monolayer of trophectodermal cells on the culture dish with a central clump of cells composed of ICM derivatives. In vitro trophectoderm attachment and outgrowth are also observed in zygotic E-cadherin-null and in aE-catenin-null embryos (Larue et al., 1994; Torres et al., 1997) . In the in vitro culture conditions, 44% of vezatin-null embryos were however not able to hatch. This is most likely due to the non physiological culture conditions. Hatching in vivo depends both on the continuing expansion of the blastocoele and on zonalytic activity triggered by the uterus (Cross et al., 1994) . By contrast, in the in vitro culture system, escape from the ZP depends only on the continuing expansion of the embryo until it succeeded to crack the ZP and to escape through the crack. Defects in the organization of junctions due to the loss of vezatin would lead to a leakage of the epithelial seal and to a retraction of the blastocoele, thus impairing in vitro hatching. Since the percentage of deciduae containing a resorbed embryo (empty deciduae) match the expected number of homozygous mutants, this suggests that vezatin-null embryos are able to hatch and to induce a decidual reaction in vivo, most likely because the epithelial seal is maintained for a longer time.
The loss of vezatin from the plasma membrane in vezatin-null embryos, the absence of phenotype in heterozygous embryos and the absence of truncated proteins in immunoblots support the idea that the observed mutant phenotype is due to a loss-of-function rather than a dominant-negative effect of a truncated vezatin. This results in the loss of E-cadherin and bcatenin from the plasma membrane. Zygotic E-cadherin invalidation leads also to a delocalization of junctional proteins from the plasma membrane (Ohsugi et al., 1997) . In aE-catenin-null embryos, no obvious change is found in the intensity of either E-cadherin or b-catenin at the plasma membrane (Torres et al., 1997) . However, this '' non-canonical junctional '' defect is in agreement with the findings that deletion of the targeted a-catenin carboxy terminus does not implicate the binding site to b-catenin but includes those needed for the interaction with cytoskeletal components (Torres et al., 1997) . This is in agreement with the role of a-catenin as a dynamic and local switch protein for actin and membrane components at cell-cell contacts Yamada et al., 2005) .
In early mouse development, maternal E-cadherin is sufficient to mediate compaction at the morula stage but zygotic gene activity is required for the proper initiation and maintenance of the first epithelium, the trophectoderm (Larue et al., 1994) . This illustrates the idea that the relative amount of cadherin on the cell surface is of major importance to allow morphogenesis. Cadherins are also linked to signaling events by interacting with various cytoplasmic cadherin-associated proteins, thereby influencing transduction pathways (Gumbiner, 2005) . These interactions implicate that cadherins could also be important players in processes such as cell proliferation, cell differentiation and cell death, all of which influence embryonic development (Peinado et al., 2004) . In tissue culture cells, it was suggested that vezatin, interacting with myosin VIIa, links indirectly a-catenin to the adherens junction and generates membrane pulling during morphogenetic movements (Kussel-Andermann et al., 2000) . The finding that myosin VIIa interacts directly with PHR1, an integral membrane protein that binds to myosin Ic, supports also a role in anchoring the cytoskeleton to the plasma membrane (Etournay et al., 2005) . Moreover, it was suggested that vezatin could indirectly link a-catenin to the adherens junction via ARF6/ARHGAP10 (Sousa et al., 2005) . We thus propose that vezatin, a protein associated to the E-cadherin-catenin complex and an indirect actin-binding protein (Kussel-Andermann et al., 2000) , has an important part to play in the generation of the adhesive forces necessary for changes in cell shape and/or movements during embryogenesis. The lack of vezatin would lead to unstable interactions between E-cadherin-catenin complex and the actin cytoskeleton at adherens junctions (D'Souza-Schorey, 2005) . Alternatively, the putative cleaved cytosolic domain of vezatin able to enter the cell nucleus (Hyenne et al., 2005) could regulate the expression of targeted genes which modulate cell adhesion (Fortini, 2002; Haas et al., 2005) .
In conclusion, we demonstrate a critical role for vezatin in early mouse embryonic development. Homozygous vezatin-null embryos develop to the blastocyst stage inducing a decidual response but die shortly after. Lack of zygotic vezatin results in peri-implantation lethality most likely because the maternal supplied protein is lost around E4.5-E5.5. Our results indicate that the absence of vezatin leads to severe defects in the assembly and/or stabilization of cell-cell adherens junctions as shown by the loss of two molecular markers, E-cadherin and b-catenin, from the plasma membrane in blastocyst outgrowths. No compensatory partner exists to counterbalance the cell-cell contact defect due to the absence of vezatin. Moreover, the absence of vezatin results in the loss of both intercellular adhesion in ICM cells and the ability of trophoblasts to interact with the uterus in a stable way. Our findings provide the first demonstration that vezatin, a member of adherens junction, is required for mammalian implantation. Finally, the use of the floxed vezatin mouse line will be valuable to analyze the role of this novel member of cell-cell junctions, in later stages of development and during differentiation.
Experimental procedures
Gene targeting and generation of mutant mice
We isolated a 4.6 kb EcoRI (129S2/SvPas, 129S2) fragment containing the genomic sequence 5 0 to exon 5 of vezatin, a 0.7 kb EcoRI/XhoI PCRderived genomic fragment (containing exon 5) flanked by one loxP site on its left edge, and a 2.4 kb ClaI/KpnI PCR-derived genomic sequence 3 0 to exon 5 of vezatin. All fragments were sequentially subcloned into Bluescript KS plasmid (Stratagene) cut with XbaI and KpnI and modified by the introduction of a XbaI-EcoRI-PvuII-XhoI-SalI-CTGTT-SphI-StuIKpnI polylinker. We introduced a floxed pPgk-1-neo-pA SalI cassette containing neo (the gene neomycine resistance for positive selection is the mutated form of neo) and a pPgk-1-DTA-pA KpnI cassette containing DTA (the Diphteria Toxin Gene for a negative selection) under the control of the Phosphoglycerate kinase-1 (Pgk-1) promoter (both cassettes were kindly provided by Drs. P. Soriano and S. Tajbakhsh). The vector was linearized with SacII and electroporated into 129S2 CK35 Embryonic Stem cells (ES) (kindly provided by Kress et al. (1998) ). 34/275 isolated ES cell clones that survived G418 selection were homologous recombinant (HR) on the basis of PCR genotyping. For ES cell diagnostic PCR genotyping (Right-arm-PCR), genomic DNA were evaluated using one primer specific to the 3 0 genomic sequence, outside the region used in the targeting vector (Ex6Rev), (5 0 -GCCTTGCGGCTTGAAAGTTGGCTCTTACGG-3 0 ) and one primer specific to the neo sequence (NeoF3), (5 0 -GCTTCCTCG TGCTTTACGGTATCGCCGCTC-3 0 ) (expected size 3 kb). PCR amplification was performed on ES DNA in a final volume of 30 ll with the TaKaRa LA Taq polymerase (Takara Bio Inc.). Samples were denatured at 94°C, 3 min and then subjected to 35 cycles of amplification (94°C, 20 s; 64°C, 30 s; 68°C, 4 min). Eight ES RH clones were further checked on the right side of the recombination event by Southern blot analysis. For Southern analysis, genomic DNA were digested with EcoRI and probed with a PCR fragment containing exon 6 as an external probe as well as with a neo probe to check the unicity and the heterozygocity of the recombination event. The homologous recombinant event was confirmed on the left side, by sequencing the junction of a 5.7 kb long range PCR fragment obtained with primers specific to the 5 0 genomic sequence, outside the region used in the targeting vector, and specific to the neo sequence. We used as a 5 0 -end primer, the primer VH1N, (5 0 -AGTCTACCCT CTTCTGATATGTGGCTATCG-3 0 ) and as a 3 0 -end primer, the primer NeoR (5 0 -AAGTGCCAGCGGGGCTGCTAAAGCGCATGC-3 0 ). PCR amplification (Left-arm-PCR) was performed on ES DNA in a final volume of 30 ll with the TaKaRa LA Taq polymerase (Takara Bio Inc.). Samples were denatured at 94°C, 3 min and then subjected to 35 cycles of amplification (94°C, 15 s; 63°C, 30 s; 68°C, 8 min). Four ES cell clones were retained of which one (clone 192) was injected into C57BL/6 N (B6) blastocysts. We obtained two highly chimeric B6.vezatin +/+ <À> 129.vezatin +/fl male chimeras (90% and 99% of coat color chimerism). We intercrossed the chimeric male mice with C57BL/6N and 129SvPas females to obtain homozygous Vezt fl/fl on a mixed 129 · B6 strain background and on a pure 129 background. Homozygous mice are fully normal and fertile.
RT-PCR
Mouse vezatin 0.8 kb isoform was identified through sequence homology search (AK041354 sequence derived from a postnatal thymus cDNA library) and cloned from in vitro cultured ES cells cDNA, using CK35 ES cells (Kress et al., 1998) of the 129S2 genotype. ES cells were first depleted of feeder layer cells DNA by culturing ES cells for 30 min on gelatinized Petri dishes followed by harvesting non adherent cells, repeated two times. Purification of mRNA and reverse transcription were processed according to Hyenne et al. (2005) . Samples corresponding to 20 embryos at the 2, 8-cell and blastocyst stages that were cultured for no more than 2 h were used to synthesize cDNAs as described (Hyenne et al., 2005) . PCR amplification was performed on 10 embryos or 20 ng of ES cDNA using the high fidelity Taq polymerase (Invitrogen). Samples were denaturated at 94°C, 2 min, and then subjected to 35 cycles of amplification (94°C, 15 s; 62°C, 20 s; 68°C, 2 min). Primers used for amplifying the full vezatin 0.8 kb cDNA contain the initiator codon within exon 1 (Veza-5 0 ) and the stop codon within the last coding exon (Veza-0.8-3 0 ). The primers were the following: Veza-5 0 : 5 0 -AGGATGACACCGGAGTTTGACGAAG-3 0 and Veza-0.8-3 0 : 5 0 -TCATGTTAAGTCCATGATATGGGTAAAAG-3 0 . The new early-expressed mouse vezatin cDNA is identified as DQ025533. The following E-cadherin specific primers were used: CadhEx1: 5 0 -CTTTTCC GCGCTCCTGCTC-3 0 and CadhEx12: 5 0 -AACTGCATGTTTCGAG GTTCTGGG-3 0 (Hyenne et al., 2005) . Database searches for protein homology used CLUSTAL W, version 1.83.
Genotyping
For newborn or adult PCR genotyping, genomic DNA from tail clippings were used as template. Tail DNA was extracted according to Laird et al. (1991) and resuspended in 100-200 ll in Tris pH 8.0, 1 mM EDTA. Two microliters were used for PCR (30 ll final). The PCR amplification protocol (Taq Polymerase using buffer containing 2.5 mM MgCl 2 , Promega), consisted of an initial incubation at 94°C for 3 min, followed by 30 cycles at 94°C for 30 s, (x)°C for 30 s and 72°C for (y) s with a final incubation at 72°C for 5 min. Numbers for (x)°C and (y) s are given below in parenthesis, according to the various allelic primers combination. The size of the expected PCR band is included in each case.
Note that in case of the dfl-and the wt-1-PCR, the same combination of primers are used, but at two different elongation times. This results in a band preferentially amplified for each combination (black arrowhead in Fig. 2 , Supplementary data) with the appearance of a product corresponding in each case, to the other allele present (empty arrowhead in Fig. 2 , Supplementary data).
For dissected embryos at E6.5 and embryonic outgrowths, embryos were lyzed into 10 ll of lysis buffer (10 mM Tris, pH 8.5, 50 mM KCl, 0.01% gelatin, 300 lg/ml proteinase K) for 50 min at 50°C followed by an inactivation step of 10 min at 90°C. Five microliters of genomic DNA from whole embryos or outgrowths were used as template in 20 ll final (Taq Polymerase using buffer containing 2.5 mM MgCl 2 , Promega), using a mixture of the following primers: ReR1, 5 0 -GCTAGGTGCTTA AAGCTATCCCACAACTCC-3 0 , FOR1, 5 0 -GGTGAAGGCTCGGCTA TTGGCTGC-3 0 and VezaF3R2, 5 0 -GAACCAGGCCAGTGGTCAGTA AGTCTCAAC-3 0 . The PCR amplification consisted of an initial incubation at 94°C for 3 min, followed by 30 cycles at 94°C for 30 s, 60°C for 30 s and 72°C for 40 s with a final incubation at 72°C for 5 min. The combination of ReR1 and FOR1 detected the wild type allele, wt-2, generating a band of 361 bp. The combination of ReR1 and VezaF3R2 detected the fully defloxed allele, dfl, generating a band of 410 bp.
For E3.5 blastocysts cultured for one day, we used a first round of PCR followed by nested PCR. Five microliters of the wt-2 PCR product were re-amplified using ReR1-N (5 0 -GCTTAAAGCTATCCCACAA CTCCCTATTGC-3 0 ) and A34TM-R (5 0 -CGTGGGAAACATGATGA GCAAAC-3 0 ) to detect the wild type allele and 5 ll of the defloxed PCR product were re-amplified using ReR1-N in combination with VezaF3R (5 0 -GAACCAGGCCAGTGGTCAGTAAG-3 0 ) to detect the defloxed allele. The nested PCR amplification consisted of an initial incubation at 94°C for 3 min, followed by 30 cycles at 94°C for 30 s, 58°C for 30 s and 72°C for 40 s with a final incubation at 72°C for 5 min.
Early embryo isolation and in vitro culture
Superovulated heterozygous Vezt dfl/+ females were crossed with heterozygous Vezt dfl/+ males and successful matings checked by the presence of a vaginal plug. The vaginal plugs were scored as gestation day E0.5 (0.5 post-coitum or 0.5 pc). Blastocysts were collected at embryonic day 3.5 (E3.5) by flushing uteri with ES cell medium without LIF and supplemented with 20 mM Hepes. For in vitro culture, blastocysts were placed individually for 3.5 days in ES cell medium without LIF onto 0.1% gelatin coated Petri dishes and photographed every 24 h (Leica DMIL and Nikkon Coolpix900) (Artus et al., 2005) . Heterozygous Vezt dfl/+ intercrosses were generated to collect embryos at E8.5 (0-2 somites) and E9.5 (18-20 somites) in cold DMEM medium.
Histochemistry
Deciduae from heterozygous Vezt dfl/+ intercrosses were entirely sectioned, stained and carefully examined. For E6.0, the implantation sites were visualized by intravenous injections (0.1 ml/mouse) of 1% Chicago Blue B in saline (McLaren, 1970) . The deciduae were fixed for 4 h in Bouin's fixative, dehydrated and embedded in paraffin. Sections (7 lm) were stained with hematoxylin and eosin by standard procedures.
Immunofluorescence and antibodies
Blastocyst outgrowths were fixed with cold methanol for 5 min at À20°C, quenched with NH 4 Cl for 15 min and permeabilized for 4 min with a mixture of 0.1% Triton-X100/PBS/0.125% cold water fish skin gelatin (Sigma). When the immunofluorescence experiments were performed after two days in culture, the zona pellucida was removed by a brief incubation in Tyrode's acid solution of the non-dezonated cultured embryos (Nicolson et al., 1975) . Outgrowths were incubated in blocking solution containing PBS/0.25% cold water fish skin gelatin for 30 min. Immunocytological staining was performed by incubation with the primary antibody in PBS/0.125% cold water fish skin gelatin overnight at 4°C, followed by an incubation in the secondary antibody in PBS/0.125% cold water fish skin gelatin for 45 min at room temperature. The affinity-purified rabbit antibody raised against the mouse C-terminus region of vezatin (Hyenne et al., 2005; Kussel-Andermann et al., 2000) was diluted at 1/200. A rat monoclonal antibody against the murine uvomorulin/E-cadherin (Vestweber and Kemler, 1985) (DECMA-1, Sigma) and a mouse monoclonal antibody against the murine b-catenin (C19220, Transduction Laboratories) were used at 1/1600 and 1/250, respectively. The fluorophore-conjugated secondary antibodies were a goat anti-rabbit Alexa fluor-488 (Molecular probes, Invitrogen), a donkey anti-rat Cy3 and a donkey anti-mouse Cy5 (Jackson Laboratories) used at 1/400, 1/250 and 1/250 respectively. Fixed outgrowths were observed with a Leica TCS-SP2 AOBS confocal microscope.
Western blot analysis
Testis/epididymis and brain tissue samples from adult mice were homogenized in extraction buffer (50 mM, Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM, MgCl 2 ) by ultrasonic vibration. A protein inhibitor mixture (Complete-EDTA free, Invitrogen) was added. The concentration of proteins in the homogenate was established by the BCA-method. Fifty micrograms of proteins were added to each lane of 10% gels (SDS-PAGE). Proteins were blotted to a PVDF-membrane in a tank blotter. The membranes were blocked in PBS/0.1% Tween 20 containing 5% dry milk followed by an overnight incubation at 4°C with the affinity-purified antivezatin antibodies (see above) or with the rabbit immune serum hA34P1 raised against a peptide in the extracytoplasmic region of the human vezatin, homologous to the mouse sequence (Hyenne et al., 2007; Kussel-Andermann et al., 2000) , at 1/1000. Secondary antibody was goat anti-rabbit HRP (Molecular Probes, Invitrogen). Proteins were detected using the ECL Western blotting detection System (Amersham). Relational quantification was carried out using the ImageJ software (version 1.36b, http://rsb.info.nih.gov/ij), using a-tubulin (8/10000) as standard.
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